Brief: Effector Therapeutics Reports Fourth Quarter And Full Year 2022 Financial Results And Provides Corporate Update
March 8 (Reuters) - eFFECTOR Therapeutics Inc EFTR.O :
* EFFECTOR THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* EFFECTOR THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.22
Source text for Eikon: ID:nGNX6v8BmY
Further company coverage: EFTR.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Effector Therapeutics
See all newsBrief: Effector Therapeutics Expects To Incur One-Time Charges And Cash Expenditures
Brief: Effector Therapeutics Announces It Will Wind Down Operations
Brief: Effector Therapeutics To Collaborate With The Dana-Farber Cancer Institute
eFFECTOR Therapeutics Inc reports results for the quarter ended in January - Earnings Summary
Brief: eFFECTOR Therapeutics Enters Into An At The Market Offering Agreement With H.C. Wainwright